Remove 2002 Remove Cannabinoids Remove Clinical Trials
article thumbnail

Best strains and terpenes for focus and flow state

The Cannigma

There is certainly some evidence that cannabis may be helpful with increasing focus, in the right dose with the right terpenes and cannabinoids. The short answer is maybe – it depends on several factors, including the cannabinoids and terpenes in your weed, as well as how much you consume. It starts with the right cannabinoids.

Terpenes 128
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Its use in China, Tibet, India, Nepal, Japan (McPartland and Hegman 2018 , Touw 1981 ), Ancient Greece and Rome (Butrica 2002 ), and Iran, Iraq, Turkey, Syria, and the Balkans (McPartland and Hegman 2018 ; Lozano 1997 ; Aldrich 1997 ) goes back thousands of years. Bonini et al. 2016 ; Sznitman et al. years (Atakan 2012 ). Discussion.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Study: Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index

Cannabis Law Report

Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. Cannabis Cannabinoid Res. 9-tetrahydrocannabinol on driving performance: a randomized clinical trial. JAMA Pediatr. 2017;171:142–9. Article Google Scholar. Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, et al.

Policy 45
article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

article thumbnail

Why we haven’t cured cancer

Otherside Farms

Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain.

article thumbnail

NO BRAINER: CBD AND THC FOR HEAD INJURIES

Green Relief

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64
article thumbnail

Green Relief - Untitled Article

Green Relief

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.